| Trial Identifier: | D6401C00004 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03682497 |
| Start Date: | November 2018 |
| Primary Completion Date: | March 2020 |
| Study Completion Date: | March 2020 |
| Condition: | Congestive Heart Failure |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English version | |
| Bulgarian Translation | |
| Czech Translation | |
| Polish Translation |
| Country | Location |
|---|---|
| Bulgaria | Plovdiv, Bulgaria, 4002 |
| Bulgaria | Sofia, Bulgaria, 1784 |
| Bulgaria | Sofia, Bulgaria, 1309 |
| Czech Republic | Brandys nad Labem, Czech Republic, 250 01 |
| Czech Republic | Ceska Lipa, Czech Republic, 470 77 |
| Czech Republic | Jaromer, Czech Republic, 551 01 |
| Czech Republic | Louny, Czech Republic, 440 01 |
| Czech Republic | Pardubice, Czech Republic, 530 02 |
| Czech Republic | Praha, Czech Republic, 130 00 |
| Czech Republic | Praha, Czech Republic, 140 59 |
| Poland | Katowice, Poland, 40-081 |
| Poland | Kraków, Poland, 31-202 |
| Poland | Legnica, Poland, 59-220 |
| Poland | Warszawa, Poland, 02-097 |
| Poland | Wrocław, Poland, 50-981 |
| United Kingdom | HULL, United Kingdom, HU3 2JZ |
| United Kingdom | Leicester, United Kingdom, LE3 9PQ |
| United Kingdom | Sheffield, United Kingdom, S5 7AU |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company